GT Biopharma, Inc. — Director's Dealing 2004

Jun 29, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OXIS INTERNATIONAL INC (OTTCBB)
CIK: 0000109657
Period of Report: 2004-06-29

Reporting Person: RODELL TIMOTHY C JR (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-06-22	Stock Option (right to buy)	$0.57	A	15000	Acquired	2014-06-21	common stock (15000)	Direct